Quanex Building Products (NX) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
28 Jan, 2026Executive summary
Annual Meeting scheduled for February 26, 2026, to elect eight directors, approve executive compensation, and ratify the appointment of a new independent auditor for fiscal 2026.
Board recommends voting in favor of all proposals and emphasizes the importance of shareholder participation.
Proxy materials include detailed information on voting procedures, director nominees, executive compensation, and governance.
Voting matters and shareholder proposals
Shareholders will vote on: (1) election of eight directors for one-year terms, (2) advisory approval of named executive officer compensation, and (3) ratification of KPMG LLP as the new independent auditor.
Board recommends a “FOR” vote on all proposals.
Shareholders may submit proposals and director nominations for the 2027 meeting, following specific advance notice and disclosure requirements.
Board of directors and corporate governance
Eight director nominees, all with significant industry, operational, and governance experience, are standing for election; all but one are independent under NYSE standards.
Board committees (Audit, Compensation & Management Development, Nominating & Corporate Governance, Executive) are composed solely of independent directors.
Board leadership structure combines Chairman and CEO roles with an independent Lead Director.
Corporate Governance Guidelines address director qualifications, independence, diversity, and mandatory retirement age.
Latest events from Quanex Building Products
- Net sales rose 2.3% to $409.1 million, but adjusted EBITDA margin declined to 6.7%.NX
Q1 20266 Mar 2026 - Q2 sales declined but margins improved; FY24 guidance and Tyman acquisition progress reaffirmed.NX
Q2 20241 Feb 2026 - Q3 results met expectations; Tyman acquisition closed, integration progressing, and FY24 guidance raised.NX
Q3 202421 Jan 2026 - Tyman acquisition drove record sales and margin gains, with a 2025 rebound expected.NX
Q4 202411 Jan 2026 - Q3 sales jumped 77% with Tyman, but a $302.3M goodwill impairment led to a $276M net loss.NX
Q3 202531 Dec 2025 - Targets ~$4B revenue by 2029, leveraging Tyman synergies, innovation, and margin expansion.NX
Investor Day 202529 Dec 2025 - Sales up 67% in Q1, net loss $14.9M, guidance reaffirmed, synergy and margin gains on track.NX
Q1 202526 Dec 2025 - Net sales up 43.8% to $1.84B; Monterrey recovery and strong cash flow drive debt reduction.NX
Q4 202513 Dec 2025 - Shareholders to vote on Quanex’s £788M acquisition of Tyman, with up to 32% ownership for Tyman holders.NX
Proxy Filing1 Dec 2025